PL447471A1 - Sposób wytwarzania wytworów polimerowych - Google Patents

Sposób wytwarzania wytworów polimerowych

Info

Publication number
PL447471A1
PL447471A1 PL447471A PL44747124A PL447471A1 PL 447471 A1 PL447471 A1 PL 447471A1 PL 447471 A PL447471 A PL 447471A PL 44747124 A PL44747124 A PL 44747124A PL 447471 A1 PL447471 A1 PL 447471A1
Authority
PL
Poland
Prior art keywords
inflorescences
hemp
liquid
polymer products
manufacturing polymer
Prior art date
Application number
PL447471A
Other languages
English (en)
Inventor
Joanna Trybuła-Chmielewska
Original Assignee
Joanna Trybuła-Chmielewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joanna Trybuła-Chmielewska filed Critical Joanna Trybuła-Chmielewska
Priority to PL447471A priority Critical patent/PL447471A1/pl
Publication of PL447471A1 publication Critical patent/PL447471A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C13/00—Dental prostheses; Making same
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/02—Solvent extraction of solids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dentistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób wytwarzania wytworów polimerowych (1) zawierających związki CBD. Sposób ten charakteryzuje się tym, że: do cieczy (2a) zawierającej monomery wprowadza się kwiatostany konopi siewnej (3), następnie, po samoczynnej ekstrakcji związków zawartych w kwiatostanach konopi siewnej, w tym związków CBD, z cieczy tej (2b) usuwa się kwiatostany konopi siewnej (3), a następnie uzyskaną ciecz (2b) łączy się z proszkiem (4) zawierającym polimery i formuje wytwór polimerowy (1). Kwiatostany konopi siewnej (3) są w postaci świeżej lub jako susz.
PL447471A 2024-01-05 2024-01-05 Sposób wytwarzania wytworów polimerowych PL447471A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL447471A PL447471A1 (pl) 2024-01-05 2024-01-05 Sposób wytwarzania wytworów polimerowych

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL447471A PL447471A1 (pl) 2024-01-05 2024-01-05 Sposób wytwarzania wytworów polimerowych

Publications (1)

Publication Number Publication Date
PL447471A1 true PL447471A1 (pl) 2025-07-07

Family

ID=96260873

Family Applications (1)

Application Number Title Priority Date Filing Date
PL447471A PL447471A1 (pl) 2024-01-05 2024-01-05 Sposób wytwarzania wytworów polimerowych

Country Status (1)

Country Link
PL (1) PL447471A1 (pl)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018052936A1 (en) * 2016-09-13 2018-03-22 Carnegie Mellon University Therapeutic acrylates as enhanced medical adhesives
WO2020186077A1 (en) * 2019-03-12 2020-09-17 6th Wave Innovations Corp. Molecularly imprinted polymers for extraction of cannabinoids and uses thereof
US20210322365A1 (en) * 2020-04-17 2021-10-21 University Of Connecticut Polycannabinoids, compounds, compositions and methods of use
WO2023182941A2 (en) * 2022-03-24 2023-09-28 Agency For Science, Technology And Research A polymerizable composition, a three-dimensional printed article and methods of preparing the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018052936A1 (en) * 2016-09-13 2018-03-22 Carnegie Mellon University Therapeutic acrylates as enhanced medical adhesives
WO2020186077A1 (en) * 2019-03-12 2020-09-17 6th Wave Innovations Corp. Molecularly imprinted polymers for extraction of cannabinoids and uses thereof
US20210322365A1 (en) * 2020-04-17 2021-10-21 University Of Connecticut Polycannabinoids, compounds, compositions and methods of use
WO2023182941A2 (en) * 2022-03-24 2023-09-28 Agency For Science, Technology And Research A polymerizable composition, a three-dimensional printed article and methods of preparing the same

Similar Documents

Publication Publication Date Title
ATE231893T1 (de) Verfahren zur modifizierung von dispersionspulver-zusammensetzungen
PL447471A1 (pl) Sposób wytwarzania wytworów polimerowych
ATE478178T1 (de) Verfahren zur herstellung von fasern aus polyethylen mit ultrahohem molekulargewicht
BR0305988A (pt) Método de preparação de um produto de lyocell
CN112724415A (zh) 一种可水下强粘附的粘合剂及其制备方法和应用
Zhang et al. The controlled release of growth factor via modified coaxial electrospun fibres with emulsion or hydrogel as the core
Romanelli Vicente Bertolo et al. Rheological study of the incorporation of grape seed extract in chitosan and gelatin coatings
CN106589264B (zh) 一种丙烯酸基复合水凝胶的制备方法
Gan et al. Chitosan-based injectable porous microcarriers with enhanced adipogenic differentiation and angiogenesis for subcutaneous adipose tissue regeneration
BR112021022208A2 (pt) Métodos para tratamento de distrofia muscular usando oligonucleotídeos inibidores para cd49d
CN113288861B (zh) 一种高强度医用材料及其制备方法
PL424419A1 (pl) Sposób otrzymywania bioaktywnego biomateriału kompozytowego polimerowo - ceramicznego
WO2019239323A3 (en) Accelerated hydrolysis system
DE60324038D1 (de) Verfahren zum herstellen von polyethylenfasern mit ultrahohem molekulargewicht
CN106367186A (zh) 一种植物油基可降解型润滑油
Sun et al. An organic-inorganic composite bone cement based on oxidized carboxymethyl cellulose/carboxymethyl chitosan hydrogel and magnesium phosphate with excellent antibacterial and antioxidant properties
CN103562277A (zh) 用于加工纤维素膜或成形制品的方法
Pan et al. Preparation and swelling behavior of polyvinyl alcohol physiological saline gel
Mohamed Khalid et al. Rheological properties of cassava starch-kaffir lime film solutions
CN104152064A (zh) 超薄pvc胶布
PL448326A1 (pl) Folia aktywna na bazie ekstraktu z żołędzi oraz sposób jej wywarzania
PL432720A1 (pl) Sposób otrzymywania hydrożelowego materiału opatrunkowego
CN103320099A (zh) 石油钻井液降粘剂及其制备方法和使用方法
PL431264A1 (pl) Sposób otrzymywania olejku eterycznego z surowców roślinnych metodą hydrodestylacji z chemiczną modyfikacją
김상훈 et al. Characterization on tubular double-layered PLCL scaffolds for vascular tissue engineering & in vivo canine study